1-3 of 3
Lorna Barnett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quantitation of WT1 Transcripts by Copy Number Provides a Sensitive Indication of Minimal Residual Disease (MRD) and Response to Adoptive Cell Therapy in Patients Transplanted for Ph(+) CML.

Annamalai Selvakumar, PhD, Aisha Hasan, MD, Vidhi Desai, MS, Gianfranco Pittari, MD, Lorna Barnett, BS, Esperanza B Papadopoulos, MD, Richard J O'Reilly, MD
Journal: Blood
Blood (2009) 114 (22): 4489.
https://doi.org/10.1182/blood.V114.22.4489.4489
Published: 2009
Journal Articles

Artificial Antigen-Presenting Cells Permit Selective In Vitro Generation of CMV-Specific T-Cells of Desired HLA Allelic Restriction for Adoptive Immunotherapy in Recipients of HLA Disparate Allografts.

Deepa Trivedi, MD, Wouter J.W. Kollen, MD, PhD, Lorna Barnett, Michel Sadelain, MD, PhD, Richard J. O’Reilly, MD
Journal: Blood
Blood (2005) 106 (11): 1298.
https://doi.org/10.1182/blood.V106.11.1298.1298
Published: 2005
Journal Articles

Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell–depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire

Stephanie Verfuerth, Karl Peggs, Paulomi Vyas, Lorna Barnett, Richard J. O'Reilly, Stephen Mackinnon
Journal: Blood
Blood (2000) 95 (12): 3990–3995.
https://doi.org/10.1182/blood.V95.12.3990
Published: 2000